# Aizant Drug Research Solutions Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aizant-drug-research-solutions-pvt

- Industry: Pharmaceuticals
- Headquarters: Hyderabad, India
- Website: www.aizant.com
- Total disclosed funding: $5M
- Latest round: Series A (Jan 20, 2011)
- Investors on record: 1

## About

Aizant Drug Research Solutions Pvt. Ltd. is a Hyderabad-based company specializing in integrated drug development and pharmaceutical solutions, offering a range of services from R&D to clinical research and manufacturing.Founded in 2005 in Hyderabad, India, Aizant Drug Research Solutions Pvt. Ltd. focuses on providing comprehensive drug development services. The company has completed a total of 3 deals. In the latest funding round in 2023, Aizant raised INR 601.950 mn, bringing the total amount raised to INR 601.950 mn and achieving a current company valuation of INR 4006.377 mn. The CEO, Varma Rudraraju, has an extensive background in the pharmaceutical industry.Aizant Drug Research Solutions Pvt. Ltd. specializes in providing integrated drug development and pharmaceutical solutions, including Research and Development (R&D), Contract Development and Manufacturing (CDMO), Contract Manufacturing Organization (CMO), and Clinical Research Organization (CRO) services. Their offerings include formulation development, analytical testing, clinical trial management, and scalable manufacturing, addressing the needs of pharmaceutical clients in various therapeutic areas such as cardiovascular, anticancer, antidiabetic, and antiviral drugs, with markets in the United States, Canada, Europe, and beyond.In 2023, Aizant's revenue amounted to INR 23,825,251, with an EBITDA of INR 5,789,409.5. The company operates through B2B transactions, engaging pharmaceutical and biotechnology firms for services like pre-formulation studies and commercial manufacturing under structured contracts designed to meet specific project needs, while ensuring regulatory compliance in product delivery.Aizant Drug Research Solutions Pvt. Ltd. aims to leverage its recent funding of INR 601.950 mn to enhance its service offerings and expand into new geographical markets. The company is focusing on developing new products tailored for the evolving pharmaceutical landscape and is targeting expansion into North America and Europe by 2025. Invascent Capital Partners acquired Aizant, with financial details of the deal remaining undisclosed, which is likely to further support Aizant's strategic growth initiatives.

## Funding rounds

- Series A, Jan 20, 2011, $5M — Zephyr Management

## Investors

- Zephyr Management (https://capitalatlas.ai/funds/zephyr-management) — Series A